Live Breaking News & Updates on Inflammation Program Immune Modulation Section

Stay updated with breaking news from Inflammation program immune modulation section. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

OncoPep Completes $11 Million Series D Financing to Continue Clinical Trials and Advance Pipeline Development

/PRNewswire/ OncoPep, Inc., a developer of transformative immunotherapeutics, announced $11 million in Series D funding. The Series D was led by Tera. ....

United States , United Kingdom , Kendall Square , Christopher Bahl , Michael Krepps , Kukje Pharma , Dennis Klinman , National Cancer Institute , Inflammation Program Immune Modulation Section , Sx Company , Dartmouth University , University Of Pennsylvania , Oncopep Inc , University Of Maine , Institute For Protein Innovation , Tera Science , Massachusetts Based Oncopep , Boston Kendall , Scientific Advisory , Senior Investigator , Inflammation Program , Immune Modulation , Protein Design , Protein Innovation ,

OncoPep Completes $11 Million Series D Financing to Continue Clinical Trials and Advance Pipeline Development

/PRNewswire/ OncoPep, Inc., a developer of transformative immunotherapeutics, announced $11 million in Series D funding. The Series D was led by Tera. ....

United States , United Kingdom , Kendall Square , Christopher Bahl , Michael Krepps , Kukje Pharma , Dennis Klinman , National Cancer Institute , Inflammation Program Immune Modulation Section , Sx Company , Dartmouth University , University Of Pennsylvania , Oncopep Inc , University Of Maine , Institute For Protein Innovation , Tera Science , Massachusetts Based Oncopep , Boston Kendall , Scientific Advisory , Senior Investigator , Inflammation Program , Immune Modulation , Protein Design , Protein Innovation ,